# Lithium Treatment for Patients With Spinocerebellar Ataxia Type I

> **NCT00683943** · PHASE1 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 13 (actual)

## Conditions studied

- Spinocerebellar Ataxia Type I

## Interventions

- **DRUG:** Lithium Carbonate

## Key facts

- **NCT ID:** NCT00683943
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05-18
- **Primary completion:** 2010-02-25
- **Final completion:** 2010-02-25
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683943, "Lithium Treatment for Patients With Spinocerebellar Ataxia Type I". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00683943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*